Not yet recruiting NCT07117552
Study for Patients With Connective Tissue Diseases Who Suffer From Pleuropulmonary Symptoms Clinically and Radiologically
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Connective Tissue Diseases. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Clinical and Radiological Pattern of Pleuropulmonary Affection in Patients With Connective Tissue Diseases
Overview
Study for clinical and radiological presentation of patients with connective tissue diseases who complain from pleuropulmonary symptoms
Primary outcome measures
- assess clinical presentation and radiological pattern of pleuropulmonary affection in patients with connective tissue diseases, and evaluate their effect in outcome of connective tissue diseases [Time frame: Day 1 admission]
Eligibility criteria
Inclusion criteria
- Patients who have diagnosed as connective tissue disease Presented by pleuropulmonary affection
Exclusion criteria
- Patients who presented by pleuropulmonary affection due to disease other than connective tissue diseases
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Egypt · 1 center
- Sohag university hospital — Sohag
Identifiers
NCT: NCT07117552 · soh-med--25-7-3MS